Skip to main content
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Clinical Diabetes
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • Log out
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Spectrum

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Clinical Diabetes
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Diabetes Spectrum
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
Departments

Diabetes and Behavior in the 21st Century: Things That Make You Go “Hmmm . . . ”

  1. Tim Wysocki
  1. Nemours Children’s Health System, Jacksonville, FL
  1. Corresponding author: Tim Wysocki, Tim.Wysocki{at}nemours.org
Diabetes Spectrum 2019 Feb; 32(1): 76-80. https://doi.org/10.2337/dsi18-0001
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Abstract

Editor's Note: This article is adapted from the address Dr. Wysocki delivered as the recipient of the American Diabetes Association’s Richard R. Rubin Award for 2018. This award recognizes a behavioral researcher who has made outstanding, innovative contributions to the study and understanding of the behavioral aspects of diabetes in diverse populations. Dr. Wysocki delivered the address in June 2018 at the association’s 78th Scientific Sessions in Orlando, Fla.

I am so honored to have been selected as the 2018 recipient of the American Diabetes Association’s (ADA’s) Richard R. Rubin Award, especially since I was fortunate to have gotten to known Dick quite well over the 25 or so years of our friendship and collegiality. Dick was truly one of the finest, most centered people I have ever known, and I tried in my lecture to emulate some of the unique style he brought to his role as a highly accomplished speaker and motivator. I strongly encourage you to learn more about him in his 2008 autobiographical article in Diabetes Spectrum (1) and in Mark Peyrot’s touching memorial to Dick that was published in Diabetes Care in 2017 (2), a few years after Dick’s untimely passing in 2013. You can also hear directly from him in a YouTube video that ADA produced when Dick was ADA President, Health Care & Education, in 2006–2007 (3).

Dick Rubin lives on in the hearts and minds of thousands of people with diabetes and clinicians who have benefitted from his wisdom and compassion over the years. He dedicated most of his career to improving the psychological experiences of people with diabetes, and I hope I can help readers develop some of his passion for contributing something of yourselves to behavioral science research in diabetes and to advocate for its broad dissemination into clinical practice.

In approaching this task, it became clear that I am not very comfortable with the concept of individual awards for accomplishments in a clinical/scientific domain such as this one, in which the major steps forward consist increasingly of transdisciplinary and multicenter collaborations, stakeholder engagement, and international arrangements. Acknowledging the droves of fine people—my loving wife, Marcia; kids with diabetes, their parents, and families; countless pediatric endocrinologists, diabetes educators, nurses, and dietitians; my colleagues in psychology, psychiatry, and various behavioral sciences, especially the 13 past recipients of this award who are listed in Table 1; industry representatives; and advocates within ADA, JDRF, the International Society for Pediatric and Adolescent Diabetes, the International Diabetes Federation, and the National Institutes of Health who have bolstered my ability to contribute to this science and its clinical application—would consume all of my available space. So, let me just thank all of you collectively because this award is really a credit and honor to all of you as much as it is to me.

View this table:
  • View inline
  • View popup
TABLE 1.

Past Recipients of the Richard R. Rubin Award and Its Predecessor, the Lilly Lecture

My intention for this published version of my lecture is to try to take a broad perspective of behavioral and psychological research in diabetes by cataloging some of the major past achievements, evaluating our current evidence base, commenting on several ongoing developments in our field, and forecasting some directions the field might take in the coming decade or so. This will not be an exhaustive review. Rather, I will try to offer a high-level perspective of our field, its contributions to elevating diabetes care, and its immediate and near- term future. Although I will mention a few exemplary studies along the way, I selected them as illustrations of the scope of our field and of the levels of sophistication and refinement that have been achieved in our short history as a focus of scientific inquiry and collaboration. I hope that these will acquaint some readers with the scope and depth of behavioral science focused on the complexities of living with diabetes. I’ll conclude with some questions and observations that perplex me about the prospects for our little scientific niche—issues that may also make you go, “Hmmm . . . .”

Where Have We Been?

In the past four decades or so, there has been an explosion of behavioral science research across the life span on how living with diabetes affects, and is affected by, a plethora of psychological processes and mechanisms at the levels of individual patients, family and spousal relationships, extra-familial social networks, the health care system, and broader communities. This extensive research has yielded a massive body of knowledge that provides many answers about how diabetes affects people’s psychological adjustment and how psychological variables influence diabetes self-management behavior (4–13). Application of this knowledge has led to the development and validation of many psychometrically sound measures (14–17) and demonstrations of the utility and merits of routine psychosocial screening (18–20) of people with diabetes and their families.

Numerous longitudinal studies have identified putative affective, behavioral, cognitive, and social determinants of diabetes outcomes in varied clinical populations (21–28). Many of the mechanisms that have been specified in such studies have been targeted in trials of behavioral and psychological interventions (29–39).

These related bodies of evidence have matured to the point that the ADA and the American Psychological Association have collaborated to initiate a training program offering continuing education credits to qualified psychologists, mental health counselors, and psychotherapists that equips these mental health professionals to better meet the needs of patients across the life span who are living with diabetes (40,41). Further affirmation that this evidence base is gaining influence on health care policy and clinical practice is manifest in the level of attention to psychosocial issues that appears in current treatment guidelines issued by major organizations (42–45), as well as in standards for accreditation of diabetes education programs (46) and certification of diabetes educators (47).

Where Have We Fallen Short?

Although there have been major strides in developing and expanding the evidence base, there is also considerable room for improvement in the contributions made by behavioral scientists to improving the behavioral, affective, cognitive, and social lives of people with diabetes. So, I’ve summarized in this section a few targets that I think represent valuable near-term directions for the field.

Organizations that develop and disseminate guidelines for clinical practice use one of several evidence-grading systems (48). For example, in a recent ADA position statement (43) on psychosocial care for people with diabetes, only 5 of the 31 treatment recommendations put forth were supported by the highest level of evidence (grade A). Certainly, research that can yield the most credible levels of empirical evidence is difficult and expensive, but the field must move beyond subjective, self-reported outcome measures, small sample sizes, short follow-ups, and single-center studies to maximize its impact on health care policy. Researchers should plan their work with the intention of informing and influencing decision-makers and other key stakeholders.

In the past decade, science has become increasingly open and transparent (49,50), with grant agencies and scientific journals increasingly requiring investigators to share with their scientific peers their research data, statistical syntax and output files, data dictionaries, procedural manuals, and other materials to facilitate both the understanding and replication of their investigations. Given the complexity of behavioral science protocols, particularly for intervention trials, these steps can be challenging, labor-intensive, and costly for behavioral researchers. The sensitivity of confidential psychological data also entails ethical and patient-protection considerations that tend to be far more salient in behavioral science research than in other domains of scientific inquiry. When studies are long since completed, the expectation that researchers can and will share such materials with others may run counter to commitments made in the informed consent process that may appear to prohibit the sharing of certain data. Moving forward, behavioral scientists working in diabetes should prepare to meet increased obligations to design and implement their research studies openly and transparently.

In my opinion, early behavioral research on diabetes was designed, conducted, and disseminated largely for the benefit of other behavioral scientists. It is time for the field to move beyond that perspective and toward a better understanding of how the accumulated evidence can now be brought to bear to improve the lives of people with diabetes and to minimize the adverse psychological impact of living with diabetes. The introspective stance that has characterized the field must now give way to research that penetrates clinical practice across the life span, normalizes the integration of medical and psychological care for people with diabetes, and demonstrates the conditions under which such services have favorable impact on clinical, financial, and patient-​reported outcomes.

Relatively little behavioral research in diabetes to date could be classified as dissemination and implementation science (51). Such research includes rigorous economic analyses (51–53) of psychological screening, assessment, and intervention strategies; variables affecting the adequacy of communication of scientific methods and evidence base to clinical colleagues; and influences on the mobilization of stakeholder energy among patients, family members, parents, and clinicians to promote the dissemination of behavioral science research into clinical practice. Contributions in these directions will be necessary to move this field to the next level, and early-career researchers should develop expertise in these critical methods.

Diabetes and Behavior: What’s Next?

There could not be a more exciting time to begin or nurture a career emphasizing the generation of behavioral science research in diabetes or its active dissemination into clinical practice for the benefit of people with diabetes everywhere. When I contemplate certain mega-trends that appear to be converging, I see a world of infinite possibilities and opportunities for behavioral scientists to make valuable contributions that can improve the lives of people with diabetes. Here are a few observations that support this optimism:

  • Science is becoming increasingly collaborative and transparent, as manifest by the open science movement, growth in transdisciplinary research teams, multisite and international networks and collaborations, and data-sharing initiatives (49–51).

  • There is likely to be continued growth of trends in clinical research that amplify the potential real-world relevance and value of that research, including stakeholder engagement in all phases of clinical care and research, shared medical decision-making, and patient- and family-centered care (54). Behavioral scientists are well-positioned to play a leading role in conducting research that embodies these developments.

  • There are many potential applications of dissemination and implementation science in behavioral diabetes research, and this is the domain in which the most valuable contributions remain to be made.

  • Technological advances in communication technology, glucose monitoring, insulin delivery, social media, and behavioral assessment may provide feasible, innovative alternatives to self-reported measurement of study outcomes.

  • There may be an increased role of simulation methods such as standardized patients, virtual reality, and avatar-based computerized training (55).

  • Continued advances in quantitative methods that permit sophisticated analyses of complex multivariate and longitudinal relationships could enable researchers to pose more nuanced research questions and put forth more complex hypotheses (56). Rather than simple tests of aggregated effects of a specific behavioral intervention, researchers should be better prepared to put forth and evaluate questions such as, “Under what conditions does this intervention yield its most robust effects on the primary outcome?” and “What baseline characteristics differentiate people who derive clinically meaningful benefit from this intervention from those who do not?”

What Makes Me Go “Hmmm . . .”?

Although the observations above may engender considerable optimism about behavioral science research in diabetes and its application to improve the lives of people with diabetes everywhere, some perplexing observations and questions remain.

  • How can we more effectively mobilize patients, families, and other stakeholders to demand access to evidence-based mental health services?

  • How can evidence derived from studies employing self-reported, subjective, recall-based measures influence policy and financing decisions in medical settings in which quantifiable, objective evidence is at a premium?

  • What kind of evidence will convince administrators, insurers, and purchasers of health care coverage that meaningful integration of mental health services into diabetes care makes good sense from financial, medical, and societal perspectives?

  • Optimal delivery of evidence-based psychological and behavioral assessment and intervention services for diabetes patients typically requires time, expertise, and frequent contact, all of which are in short supply. Are there more creative financing strategies that could support the routine integration of those services into care for all people with diabetes? What sources of waste can be identified and eliminated and what efficiencies can be exploited?

  • How can new diabetes technologies be introduced and disseminated in ways that reduce, rather than exacerbate, disparities in health care outcomes along racial, ethnic, socioeconomic, and health literacy dimensions?

  • What messages to patients, families, and other health care providers will reduce the stigma associated with seeking, obtaining, and maintaining mental health services to promote healthy coping with diabetes?

A large segment of the population harbors considerable distrust of science and other “fact-based” professions and institutions, tending to view with suspicion any expression of expert opinion based on expertise and methods that are difficult for nonexperts to comprehend (57). These attitudes may well impede recruitment of study participants, fulfillment of research commitments among those who do enroll, retention of participants, translation of research findings into clinical practice, and the influence of research on health care policy. Current “self-policing” trends such as training investigators in the responsible conduct of research, the emergence of open science and data sharing, and the inclusion of stakeholders in all aspects of research from conceptualization through dissemination certainly can play constructive roles, but these may do more to convince scientists of the credibility of one another’s work than to influence public opinion, policy decisions, and health care practice. Perhaps all scientists (and friends of science) share a responsibility to apply their energy and creativity to countering the anti-scientific perspective that stands to impede societal benefits from their valuable research.

Duality of Interest

No potential conflicts of interest relevant to this article were reported.

  • © 2019 by the American Diabetes Association.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See www.diabetesjournals.org/content/license for details.

References

  1. 1.↵
    1. Rubin RR
    . Diabetes: a personal history. Diabetes Spectr 2008;21:54–56
    OpenUrlFREE Full Text
  2. 2.↵
    1. Peyrot M
    . Richard R. Rubin, PhD: an ambassador for behavioral science in diabetes. Diabetes Care 2017;40:435–439
    OpenUrlFREE Full Text
  3. 3.↵
    1. American Diabetes Association
    . Richard R. Rubin, PhD, CDE: President, Health Care and Education. Posted 28 June 2013. Available from www.youtube.com/watch?v=bC_CJ-DZE_U. Accessed 5 May 2018
  4. 4.↵
    1. Peyrot M,
    2. McMurry JF Jr.,
    3. Kruger DF
    . A biopsychosocial model of glycemic control in diabetes: stress, coping and regimen adherence. J Health Soc Behav 1999;40:141–158
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.
    1. Lin A,
    2. Northam EA,
    3. Rankins D,
    4. Werther GA,
    5. Cameron FJ
    . Neuropsychological profiles of young people with type 1 diabetes 12 yr after disease onset. Pediatr Diabetes 2010;11:235–243
    OpenUrlCrossRefPubMed
  6. 6.
    1. Tonoli C,
    2. Heyman E,
    3. Roelands B, et al
    . Type 1 diabetes‐associated cognitive decline: a meta‐analysis and update of the current literature. J Diabetes 2014;6:499–513
    OpenUrlCrossRefPubMed
  7. 7.
    1. Hilliard ME,
    2. Wu YP,
    3. Rausch J,
    4. Dolan LM,
    5. Hood KK
    . Predictors of deteriorations in diabetes management and control in adolescents with type 1 diabetes. Adolesc Health 2013;52:28–34
    OpenUrl
  8. 8.
    1. Fisher L,
    2. Hessler D,
    3. Polonsky W,
    4. Strycker L,
    5. Masharani U,
    6. Peters A
    . Diabetes distress in adults with type 1 diabetes: prevalence, incidence and change over time. J Diabetes Complications 2016;30:1123–1128
    OpenUrlPubMed
  9. 9.
    1. Lawrence JM,
    2. Standiford DA,
    3. Loots B, et al
    . Prevalence and correlates of depressed mood among youth with diabetes: the SEARCH for Diabetes in Youth study. Pediatrics 2006;117:1348–13458
    OpenUrlAbstract/FREE Full Text
  10. 10.
    1. Herzer M,
    2. Hood KK
    . Anxiety symptoms in adolescents with type 1 diabetes: association with blood glucose monitoring and glycemic control. J Pediatr Psychol 2010;35:415–425
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.
    1. Iturralde E,
    2. Weissberg-Benchell J,
    3. Hood KK
    . Avoidant coping and diabetes-related distress: pathways to adolescents’ type 1 diabetes outcomes. Health Psychol 2017;36:236–244
    OpenUrlPubMed
  12. 12.
    1. Wysocki T,
    2. Taylor A,
    3. Hough BS,
    4. Linscheid TR,
    5. Yeates KO,
    6. Naglieri JA
    . Deviation from developmentally appropriate self-care autonomy: association with diabetes outcomes. Diabetes Care 1996;19:119–125
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Northam EA,
    2. Lin A,
    3. Finch S,
    4. Werther GA,
    5. Cameron FJ
    . Psychosocial well-being and functional outcomes in youth with type 1 diabetes 12 years after disease onset. Diabetes Care 2010;33:1430–1437
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Wysocki T,
    2. Nansel TR,
    3. Holmbeck GN, et al
    . Collaborative involvement of primary and secondary caregivers: associations with youths’ diabetes outcomes. J Pediatr Psychol 2009;34:869–881
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.
    1. Young V,
    2. Eiser C,
    3. Johnson B, et al
    . Eating problems in adolescents with type 1 diabetes: a systematic review with meta-analysis. Diabet Med 2013;30:189–198
    OpenUrlCrossRefPubMed
  16. 16.
    1. Varni JW,
    2. Burwinkle TM,
    3. Jacobs JR,
    4. Gottschalk M,
    5. Kaufman F,
    6. Jones KL
    . The PedsQL™ in type 1 and type 2 diabetes: reliability and validity of the Pediatric Quality of Life Inventory™ generic core scales and type 1 diabetes module. Diabetes Care 2003;26:631–637
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. La Greca AM,
    2. Bearman KJ
    . The Diabetes Social Support Questionnaire–Family Version: evaluating adolescents’ diabetes-specific support from family members. J Pediatr Psychol 2002;27:665–676
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Schwartz DD,
    2. Cline VD,
    3. Axelrad ME,
    4. Anderson BJ
    . Feasibility, acceptability, and predictive validity of a psychosocial screening program for children and youth newly diagnosed with type 1 diabetes. Diabetes Care 2011;34:326–331
    OpenUrlAbstract/FREE Full Text
  19. 19.
    1. Coroathers SD,
    2. Kichler J,
    3. Jones NHY, et al
    . Quality report: improving depression screening for adolescents with type 1 diabetes. Pediatrics 2013;132:e1395–e1402
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Hilliard ME,
    2. Herzer M,
    3. Dolan LM,
    4. Hood KK
    . Psychological screening in adolescents with type 1 diabetes predicts outcomes one year later. Diabetes Res Clin Pract 2011;94:39–44
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Bryden KS,
    2. Peveler RC,
    3. Stein A,
    4. Neil A,
    5. Mayou RA,
    6. Dunger DB
    . Clinical and psychological course of diabetes from adolescence to young adulthood: a longitudinal cohort study. Diabetes Care 2001;24:1536–1540
    OpenUrlAbstract/FREE Full Text
  22. 22.
    1. Hood KK,
    2. Huestis S,
    3. Maher A,
    4. Butler D,
    5. Volkening L,
    6. Laffel LMB
    . Depressive symptoms in children and adolescents with type 1 diabetes: association with diabetes-specific characteristics. Diabetes Care 2006;29:1389–1391
    OpenUrlFREE Full Text
  23. 23.
    1. Kovacs M,
    2. Feinberg TL,
    3. Paulauskas S,
    4. Finkelstein R,
    5. Pollock M,
    6. Crouse-Novak M
    . Initial coping responses and psychosocial characteristics of children with insulin-dependent diabetes mellitus. J Pediatr 1985;106:827–834
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.
    1. Northam EA,
    2. Anderson PJ,
    3. Werther GA,
    4. Warne GL,
    5. Adler RG,
    6. Andrewes D
    . Neuropsychological complications of IDDM in children 2 years after disease onset. Diabetes Care 1998;21:379–384
    OpenUrlAbstract/FREE Full Text
  25. 25.
    1. Rohan JM,
    2. Rausch JR,
    3. Pendley JS, et al
    . Identification and prediction of group-based glycemic control trajectories during the transition to adolescence. Health Psychol 2014:33:1143–1152
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.
    1. Hilliard ME,
    2. Wu YP,
    3. Rausch J,
    4. Dolan LM,
    5. Hood KK
    . Predictors of deterioration in diabetes management and control in adolescents with type 1 diabetes. J Adolesc Health 2013;52:28–34
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.
    1. Helgeson VS,
    2. Vaughn AK,
    3. Seltman H,
    4. Orchard T,
    5. Libman I,
    6. Becker D
    . Trajectories of glycemic control over adolescence and emerging adulthood: an 11-year longitudinal study of youth with type 1 diabetes. J Pediatr Psychol 2017;43:8–18
    OpenUrl
  28. 28.↵
    1. Barnard K,
    2. Thomas S,
    3. Royle P,
    4. Noyes K,
    5. Waugh N
    . Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review. BMC Pediatr 2010;10:50
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Grey M,
    2. Boland EA,
    3. Davidson M,
    4. Li J,
    5. Tamborlane WV
    . Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life. J Pediatr 2000;137:107–113
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.
    1. Grey M,
    2. Jaser SS,
    3. Whittemore R,
    4. Jeon S,
    5. Lindemann E
    . Coping skills training for parents of children with type 1 diabetes: 12-month outcomes. Nurs Res 2011;60:173–181
    OpenUrlCrossRefPubMed
  31. 31.
    1. Wysocki T,
    2. Harris MA,
    3. Buckloh LM, et al
    . Effects of behavioral family systems therapy for diabetes on adolescents’ family relationships, treatment adherence, and metabolic control. J Pediatr Psychol 2006;31:928–938
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.
    1. Ellis DA,
    2. Frey MA,
    3. Naar-King S,
    4. Templin T,
    5. Cunningham P,
    6. Cakan N
    . Use of multisystemic therapy to improve regimen adherence among adolescents with type 1 diabetes in chronic poor metabolic control: a randomized controlled trial. Diabetes Care 2005;28:1604–1610
    OpenUrlAbstract/FREE Full Text
  33. 33.
    1. Mulvaney SA,
    2. Rothman RL,
    3. Osborn CY,
    4. Lybarger C,
    5. Dietrich MS,
    6. Wallston KA
    . Self-management problem solving for adolescents with type 1 diabetes: intervention processes associated with an Internet program. Patient Educ Couns 2011;85:140–142
    OpenUrlCrossRefPubMed
  34. 34.
    1. Holmes CS,
    2. Chen R,
    3. Mackey E,
    4. Grey M,
    5. Streisand R
    . Randomized clinical trial of clinic-integrated, low-intensity treatment to prevent deterioration of disease care in adolescents with type 1 diabetes. Diabetes Care 2014;37:1535–1543
    OpenUrlAbstract/FREE Full Text
  35. 35.
    1. Whittemore R,
    2. Jaser SS,
    3. Jeon S, et al
    . An Internet coping skills training program for youth with type 1 diabetes: six-month outcomes. Nurs Res 2012;61:395–404
    OpenUrlCrossRefPubMed
  36. 36.
    1. Hood KK,
    2. Iturralde E,
    3. Rausch J,
    4. Weissberg-Benchell J
    . Preventing diabetes distress in adolescents with type 1 diabetes: results 1 year after participation in the STePS program. Diabetes Care 2018;41:1623–1630
    OpenUrlAbstract/FREE Full Text
  37. 37.
    1. Fisher L,
    2. Hessler D,
    3. Polonsky WH, et al
    . T1-REDEEM: a randomized controlled trial to reduce diabetes distress among adults with type 1 diabetes. Diabetes Care 2018;41:1862–1869
    OpenUrlAbstract/FREE Full Text
  38. 38.
    1. Trief PM,
    2. Fisher L,
    3. Sandberg J, et al
    . Health and psychosocial outcomes of a telephonic couples behavior change intervention in patients with poorly controlled type 2 diabetes: a randomized clinical trial. Diabetes Care 2016;39:2165–2173
    OpenUrlAbstract/FREE Full Text
  39. 39.↵
    1. Health Quality Ontario
    . Behavioural interventions for type 2 diabetes: an evidence-based analysis. Ont Health Technol Assess Ser 2009;9:1–45
    OpenUrl
  40. 40.↵
    1. American Diabetes Association
    . Mental health provider diabetes education program. Available from professional.diabetes.org/meeting/other/mental-health-provider-diabetes-education-program. Accessed 14 September 2018
  41. 41.↵
    1. American Diabetes Association
    . Mental health provider directory. Available from professional.diabetes.org/mhp_listing. Accessed 14 September 2018
  42. 42.↵
    1. American Diabetes Association
    . 6. Glycemic targets: Standards of Medical Care in Diabetes—2018. Diabetes Care 2018;41(Suppl. 1):S55–S64
    OpenUrlAbstract/FREE Full Text
  43. 43.↵
    1. Young-Hyman D,
    2. de Groot M,
    3. Hill-Briggs F,
    4. Gonzalez JS,
    5. Hood K,
    6. Peyrot M
    . Psychosocial care for people with diabetes: a position statement of the American Diabetes Association. Diabetes Care 2016;39:2126–2140
    OpenUrlFREE Full Text
  44. 44.
    1. Delamater AM,
    2. de Wit M,
    3. McDarby V, et al
    . ISPAD clinical practice consensus guidelines: psychological care of children and adolescents with type 1 diabetes. Available from www.ispad.org/forums/Posts.aspx?topic=1431341. Accessed 14 September 2018
  45. 45.↵
    1. Chiang, JL,
    2. Maahs DM,
    3. Garvey KC, et al
    . Type 1 diabetes in children and adolescents: a position statement by the American Diabetes Association. Diabetes Care 2018;41:2026–2044
    OpenUrlFREE Full Text
  46. 46.↵
    1. Beck J,
    2. Greenwood DA,
    3. Blanton L, et al.
    , on behalf of the 2017 Standards Revision Task Force. 2017 national standards for diabetes self-management education and support. Diabetes Care 2017;40:1409–1419
    OpenUrlFREE Full Text
  47. 47.↵
    1. National Certification Board for Diabetes Educators
    . 2018 certification examination for diabetes educators. Available from www.ncbde.org/assets/1/7/Handbook_Current.pdf. Accessed 14 September 2018
  48. 48.↵
    1. Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) Working Group
    . Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490–1494
    OpenUrlAbstract/FREE Full Text
  49. 49.↵
    1. National Institutes of Health
    . NIH data sharing policy and implementation guidance. Available from grants.nih.gov/grants/policy/data_sharing/data_sharing_guidance.htm. Accessed 14 September 2018
  50. 50.↵
    1. Weissgerber TL,
    2. Garovic VD,
    3. Sinham SJ,
    4. Milic NM,
    5. Prager EM
    . Transparent reporting for reproducible science. J Neurosci Res 2016;94:859–864
    OpenUrl
  51. 51.↵
    1. Glasgow RE,
    2. Vinson C,
    3. Chambers D,
    4. Khoury MJ,
    5. Kaplan RM,
    6. Hunter C
    . National Institutes of Health approaches to dissemination and implementation science: current and future directions. Am J Public Health 2012;102:1274–1281
    OpenUrlCrossRefPubMedWeb of Science
  52. 52.
    1. Jeeva F,
    2. Dickens C,
    3. Coventry P,
    4. Bundy C,
    5. Davies L
    . Is treatment of depression cost-effective in people with diabetes? A systematic review of the economic evidence. Int J Technol Assess Health Care 2013;29:384–391
    OpenUrl
  53. 53.↵
    1. Herman WH,
    2. Hoerger TJ,
    3. Brandle M, et al.
    , for the DPP Research Group. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med 2005;142:323–332
    OpenUrlCrossRefPubMedWeb of Science
  54. 54.↵
    1. Institute of Medicine
    . Patients Charting the Course: Citizen Engagement and the Learning Health System. Washington, D.C., National Academies Press, 2011
  55. 55.↵
    1. Rizzo S,
    2. Koenig ST,
    3. Talbot T
    . Clinical virtual reality: emerging opportunities for psychiatry. Focus 2018;16:266–278
    OpenUrl
  56. 56.↵
    1. Wickrama K,
    2. Lee TK,
    3. O’Neal CW,
    4. Lorenz FO
    . Higher-Order Growth Curves and Mixture Modeling with Mplus: A Practical Guide. New York, N.Y., Routledge, 2016
  57. 57.↵
    1. Funk C
    . Real numbers: mixed messages about public trust in science. Issues in Science and Technology 2017;34. Available from issues.org/34-1/real-numbers-mixed-messages-about-public-trust-in-science. Accessed 14 September 2018
PreviousNext
Back to top
Diabetes Spectrum: 32 (1)

In this Issue

February 2019, 32(1)
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Spectrum.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Diabetes and Behavior in the 21st Century: Things That Make You Go “Hmmm . . . ”
(Your Name) has forwarded a page to you from Diabetes Spectrum
(Your Name) thought you would like to see this page from the Diabetes Spectrum web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Diabetes and Behavior in the 21st Century: Things That Make You Go “Hmmm . . . ”
Tim Wysocki
Diabetes Spectrum Feb 2019, 32 (1) 76-80; DOI: 10.2337/dsi18-0001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Diabetes and Behavior in the 21st Century: Things That Make You Go “Hmmm . . . ”
Tim Wysocki
Diabetes Spectrum Feb 2019, 32 (1) 76-80; DOI: 10.2337/dsi18-0001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Where Have We Been?
    • Where Have We Fallen Short?
    • Diabetes and Behavior: What’s Next?
    • What Makes Me Go “Hmmm . . .”?
    • Duality of Interest
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Smart Connected Insulin Pens, Caps, and Attachments: A Review of the Future of Diabetes Technology
  • Brief Literature Review: The Potential of Diabetes Technology to Improve Sleep in Youth With Type 1 Diabetes and Their Parents: An Unanticipated Benefit of Hybrid Closed-Loop Insulin Delivery Systems
  • Mental Health and Behavioral Screening in Pediatric Type 1 Diabetes
Show more Departments

Similar Articles

Navigate

  • Current Issue
  • Papers in Press
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Diabetes Care
  • Clinical Diabetes
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Spectrum Print ISSN: 1040-9165, Online ISSN: 1944-7353.